Irina Lupescu

Irina Lupescu

Auto-generated profile, based on publicly available information

Irina Lupescu

National Institute for Chemical Pharmaceutical Research and Development-ICCF, Vitan Avenue 112, 031299 Bucharest, Romania | Department of Veterinary Medicine, Spiru Haret University, 256 Basarabia Blvd, 030352, Bucharest, Romania

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2017 in Biomacromolecules
Verified
Journal Article
Closed access
DPDenis Mihaela Panaitescu
Denis Mihaela Panaitescu
ILIrina Lupescu
Irina Lupescu
AFAdriana Nicoleta Frone
Adriana Nicoleta Frone
Ioana NegruIoana Negru
Ioana Negru
CNCristian Andi Nicolae
Cristian Andi Nicolae
RTRoxana Trusca
Roxana Trusca

9 August 2018 in Cellulose
Verified
Journal Article
Closed access
PDF file
DPDenis Mihaela Panaitescu
Denis Mihaela Panaitescu
AFAdriana Nicoleta Frone
Adriana Nicoleta Frone
Ioana NegruIoana Negru
Ioana Negru
CNCristian-Andi Nicolae
Cristian-Andi Nicolae
RTRoxana Trușcă
Roxana Trușcă
ILIrina Lupescu
Irina Lupescu

1 July 2022 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
NENicoleta Ene
Nicoleta Ene
MVMariana Gratiela Vladu
Mariana Gratiela Vladu
ILIrina Lupescu
Irina Lupescu
AIAna Despina Ionescu
Ana Despina Ionescu
Emanuel VamanuEmanuel Vamanu
Emanuel Vamanu
Background: Polyhydroxyalkanoates (PHAs) are bacteria-synthesized biopolymers under imbalanced growth conditions. These biopolymers are acknowledged as potential biomaterials for future applications because of their characteristics of biocompatibility and biodegradability, and ability to be produced rapidly, and strong functionality of mechanical resistance. This article aims to perform microbial fermentation using the Pseudomonas putida strain to identify the quantity of biopolymers, particularly of the medium-chain-length (mcl-PHA) polyhydroxyalkanoates, based on the type and quantity of the added precursors (glucose and fatty acids). Methods: To understand the microbial interaction and the mechanism involved in PHA biosynthesis, several methods were employed and microbial biomass was obtained using the Pseudomonas putida strain capable of producing PHA. The polymer production by acetone extraction was analyzed using the Soxhlet method, while the biopolymer purification was done via the methanol-ethanol treatment, after which the biomass estimation was done through spectrophotometric analysis. This was followed by measuring the dry weight of the cells and quantification of the biopolymer produced using the gas chromatography method (GC). Results: The highest PHA yield was obtained using the octanoic (17 mL in 2000 mL medium) and hexanoic acids (14 mL in 2000 mL medium) as the precursors. As a result, the octanoic acid - octanoic acid, heptanoic acid – nonanoic acid, and octanoic acid - hexanoic acid were identified as the different precursors that supported the quantity of PHA obtained. Conclusion: Among the 4 types of structurally related substrates, the Pseudomonas putida ICCF 319 strain showed a preference for the C8 sublayer for the biosynthesis of the elastomeric PHAs composed predominantly of more C8 monomers than the C6 and C10.

1 January 2011 in International Journal of Nano and Biomaterials
Verified
Journal Article
Closed access
MEMihaela Carmen Eremia
Mihaela Carmen Eremia
ILIrina Lupescu
Irina Lupescu
LTLuminita Tcacenco
Luminita Tcacenco
We studied the preparation of polymeric membranes formed of solutions of poly-3-hydroxybutyrate (PHB) and chitosan. PHB-chitosan biomaterials from these solutions may form various structural types, which determine the biodegradation time, the adsorption capacity, and the kinetics of the release of medicinal compounds from polymeric matrices. Serine protease inhibitors, SERPINs, continue to catch the attention of researchers because of their increasing use in medicine and biotechnology. We prepared and studied the properties of biodegradable materials containing the serine protease inhibitors, soybean trypsin inhibitor (abbreviate STI) and watermelon (Citrullus vulgaris) trypsin inhibitor (abbreviate CVTI). Properties of bioactive compounds bound to the above mentioned polymers (proteolytic activity, porous structure, and increased hydrophilicity) account for their use in two key medical applications: drug delivery and tissue engineering.